Compare BLDR & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | ELAN |
|---|---|---|
| Founded | 1998 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 12.7B |
| IPO Year | 2005 | 2018 |
| Metric | BLDR | ELAN |
|---|---|---|
| Price | $75.96 | $22.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 10 |
| Target Price | ★ $121.76 | $27.89 |
| AVG Volume (30 Days) | 2.1M | ★ 3.7M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,190,638,000.00 | $4,715,000,000.00 |
| Revenue This Year | $0.71 | $8.21 |
| Revenue Next Year | $4.52 | $5.31 |
| P/E Ratio | $20.51 | ★ N/A |
| Revenue Growth | N/A | ★ 6.22 |
| 52 Week Low | $76.50 | $9.42 |
| 52 Week High | $151.03 | $27.72 |
| Indicator | BLDR | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 31.84 | 45.08 |
| Support Level | N/A | $22.17 |
| Resistance Level | $130.47 | $22.89 |
| Average True Range (ATR) | 4.01 | 0.73 |
| MACD | -0.72 | -0.04 |
| Stochastic Oscillator | 1.51 | 32.62 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.